Comparison of CT acquired cardiac valvular calcification scores in hemodialysis and peritoneal dialysis patients undergoing open heart surgery.

CT Cardiac surgery Cardiac valvular calcification Hemodialysis Peritoneal dialysis

Journal

American heart journal plus : cardiology research and practice
ISSN: 2666-6022
Titre abrégé: Am Heart J Plus
Pays: United States
ID NLM: 101779333

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 22 09 2022
revised: 17 11 2022
accepted: 24 11 2022
medline: 1 12 2022
pubmed: 1 12 2022
entrez: 21 3 2024
Statut: epublish

Résumé

Data is scarce regarding which dialysis modality portends more severe cardiac valvular calcification (CVC). Our aim was to compare the degree of CVC in hemodialysis (HD) and peritoneal dialysis (PD) patient cohorts prior to open heart surgery (OHS) using a CT calcium score. Dialysis patients who underwent OHS at our institution from 2009 to 2019 and who had pre-surgical cardiac CT were included in our study. We obtained duration of dialysis modality prior to their surgical date. There were two study cohorts to evaluate outcomes of interest: mitral and aortic calcification. CVC was assessed using the Agatston score. Logistic regression was performed to test for the association of PD and HD cumulative dialysis duration with presence of CVC. A total of 214 and 166 patients met inclusion for the mitral and aortic strata, respectively. Age, female sex, and BMI were associated with higher odds of presence of mitral calcification. Age and BMI were associated with higher odds of presence of aortic calcification, while female sex was associated with lower odds in the aortic strata. Cumulative years on PD and cumulative years on HD were not significantly associated with presence of CVC in either cohort. Presence of mitral and aortic calcification for patients undergoing OHS was not significantly associated with cumulative length of PD or HD after adjusting for age, gender, and BMI suggesting that there may be more factors at play in the progression of CVC in end stage renal disease patients than what was previously established.

Identifiants

pubmed: 38510498
doi: 10.1016/j.ahjo.2022.100234
pii: S2666-6022(22)00151-3
pmc: PMC10946039
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100234

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript.

Auteurs

Christopher N Kanaan (CN)

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Habib Layoun (H)

Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Nicholas P Kondoleon (NP)

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Remy Fadel (R)

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Saeid Mirzai (S)

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Jesse Schold (J)

Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA.

Susana Arrigain (S)

Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA.

Remy Daou (R)

Saint Joseph University, Department of Family Medicine, Beirut, Lebanon.

Ali Mehdi (A)

Department of Kidney Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Jonathan J Taliercio (JJ)

Department of Kidney Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Shinya Unai (S)

Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, OH, USA.

Samir Kapadia (S)

Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Serge Harb (S)

Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Georges N Nakhoul (GN)

Department of Kidney Medicine, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Classifications MeSH